je.st
news
Cigna Demands Counseling for Breast Cancer Test in Myriad Threat
2013-08-19 09:48:37| Biotech - Topix.net
Cigna Corp. will become the first U.S. health insurer to require genetic counseling nationwide before it pays for tests for hereditary breast and ovarian cancer, a move that may threaten sales for Myriad Genetics Inc. The policy affects tests for the BRCA1 and BRCA2 genes, the most common cause of hereditary breast cancer, as well as genes for ... (more)
Tags: test
cancer
demands
threat
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||